Atlas Trials

Expanded Access for Fixed-Dose Combination of Nivolumab Plus Relatlimab

Clinical trial NCT05170685 · NO_LONGER_AVAILABLE

Trial details

NCT number
NCT05170685
Sponsor
Bristol-Myers Squibb
Status
NO_LONGER_AVAILABLE
Study type
EXPANDED_ACCESS

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.